###begin article-title 0
Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Muller Cells and Photoreceptors
###end article-title 0
###begin p 1
###xml 318 329 318 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">all figures</xref>
###xml 329 329 329 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002"/>
###xml 329 329 329 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003"/>
###xml 329 329 329 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g004"/>
###xml 329 329 329 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005"/>
###xml 329 329 329 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006"/>
###xml 337 345 337 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7</xref>
###xml 583 592 583 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002">Figures 2</xref>
###xml 593 593 593 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003"/>
###xml 593 593 593 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g004"/>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">5</xref>
###xml 675 684 675 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002">Figures 2</xref>
###xml 685 685 685 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003"/>
###xml 685 685 685 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g004"/>
###xml 685 686 685 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">5</xref>
###xml 776 784 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7</xref>
###xml 893 901 893 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5</xref>
###xml 1053 1062 1053 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1:</xref>
###xml 1158 1166 1158 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7</xref>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
Conceived and designed the experiments: MSG. Performed the experiments: MSG. Analyzed the data: MSG. Wrote the paper: MSG. Oversaw all aspects of the work, collaborated on study design, interpretation of results and manuscript preparation: PAD. Responsible for all aspects of the study: MSG. Contributed materially to all figures except Figure 7 and Supplemental Figures 4 and 5: MSG. Analyzed all the data, assembled the figures and wrote the first draft of the manuscript: MSG. Developed and characterized the sFlt model and assisted in characterization of the vascular phenotype (Figures 2-5): ASRM. Collaborated with mouse work and participated in the vascular analysis (Figures 2-5): TEW. Developed the method for isolation of photoreceptor sheets and is responsible for Figure 7 and Supplemental Figures 4 and 5: BAT. Carried out the analysis of retinal function via electroretinograms (Figure 5): ES. Participated in immunohistochemistry, tissue culture and RT-PCR: TK. Conducted studies on VEGF expression in the inner retina and contributed to Figure 1: DCD. Oversaw the development and characterization of photoreceptor sheets: MJY. Contributed to Figure 7 and Supplemental Figures 4 and 5: MJY.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
Using immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Muller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Muller cell line in vitro supports the existence of an autocrine role for VEGF in Muller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
These results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 540 543 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez1">[1]</xref>
###xml 836 839 836 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Darland1">[2]</xref>
###xml 841 844 841 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 955 958 955 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Marneros1">[4]</xref>
###xml 1039 1042 1039 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Marneros1">[4]</xref>
###xml 1144 1147 1141 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Stone1">[5]</xref>
###xml 1255 1258 1252 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Stone1">[5]</xref>
###xml 1301 1304 1298 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Alon1">[6]</xref>
###xml 1476 1479 1473 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Stalmans1">[7]</xref>
The retina is one of the body's most metabolically demanding tissues. To ensure adequate nutrient and oxygen delivery, the retina is supplied by two independent vascular beds, the inner retinal vasculature and outer choroidal circulation. These vascular beds have distinct morphologic properties; the inner retinal vasculature is the site of a blood-tissue barrier and is characterized by highly impermeable vessels, whereas the choriocapillaris consists of a highly fenestrated capillary plexus. Vascularization of the retina (reviewed in [1]) occurs late in gestation and is restricted to the inner retina. During development, vascular endothelial growth factor (VEGF) is expressed by astrocytes in the retinal ganglion cell layer (GCL), by cells of inner nuclear layer (INL), Muller cells, and retinal pigment epithelial cells (RPE) [2], [3]. Targeted deletion of VEGF in the RPE results in failure of choroidal development and loss of visual function [4]. Whereas formation of the choriocapillaris appears to be independent of hypoxia [4], formation of the inner retinal vasculature requires induction of the hypoxia inducible factor-1beta [5]. Hyperoxia during retinal development suppresses VEGF production resulting in reduced vascular development [5], as is seen in retinopathy of prematurity [6]. Furthermore, normal retinal vascularization requires the coordinated expression of specific VEGF isoforms, which differ in their solubility and binding to VEGF receptors [7].
###end p 9
###begin p 10
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Ferrara1">[8]</xref>
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Duh1">[9]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Ambati1">[10]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Tilton1">[11]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Gragoudas1">[12]</xref>
###xml 859 863 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Brown1">[13]</xref>
In addition to its role in developmental retinal vascularization, VEGF is upregulated in several ocular pathologies, including wet age related macular degeneration (AMD) [8] and proliferative diabetic retinopathy [9]. In AMD, injury to the RPE is thought to result in increased VEGF expression. Coupled with damage to Bruch's membrane, this leads to proliferation of choroidal vessels, which invade the subretinal space [10]. In proliferative diabetic retinopathy, the neovascularization that arises from the inner retina is mediated by hypoxia-induced VEGF (reviewed in [11]). The involvement of VEGF in AMD has led to the Food and Drug Administration approval of two intraocular anti-VEGF drugs, pegaptanib sodium (Macugen, OSI/Eyetech Pharmaceuticals, NY) [12], an aptamer which was reported to inhibits only VEGF165, and ranibizumab (Lucentis, Genentech) [13], a Fab fragment of the humanized monoclonal VEGF antibody bevacizumab (Avastin, Genentech) which neutralizes all VEGF isoforms.
###end p 10
###begin p 11
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kim1">[14]</xref>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Robinson1">[15]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Famiglietti1">[16]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Vinores1">[17]</xref>
###xml 430 434 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-DAmore1">[18]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Schanzer1">[19]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj1">[20]</xref>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Azzouz1">[21]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Wang1">[22]</xref>
###xml 704 708 704 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Spandau1">[23]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Weinberger1">[24]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maynard1">[25]</xref>
###xml 1000 1004 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Sathish1">[26]</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Saito1">[27]</xref>
###xml 589 595 <span type="species:ncbi:9606">humans</span>
While the role of VEGF in developmental and pathologic retinal vascularization is well understood, its function in the normal adult is unclear. We and others have previously reported that VEGF is expressed in the adult retina by RPE [3] as well as by neuronal and glial cells [14], [15], [16], [17]. Although initially thought to be endothelial-specific, VEGF has been shown to target a variety of non-vascular cells (reviewed in [18]) including, neural stem cells [19], ependymal cells [20] and neuronal cells of the central nervous system [21], [22]. In addition, VEGF neutralization in humans via intraocular injection of Macugen and Avastin is associated with an increased incidence of retinal tears [23], [24]. Similarly, preeclampsia, which is mediated in part by elevated circulating levels of a soluble form of VEGF receptor 1 called sFlt1 leading to systemic VEGF neutralization [25], is also associated with ocular symptoms including RPE lesions, choroidal ischemia and retinal detachments [26], [27].
###end p 11
###begin p 12
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
Given the expression of VEGF and VEGF receptor 2 (VEGFR2) in the adult retina, and the constitutive activation of the receptor, we hypothesized that VEGF plays a role in maintenance and function of the adult retina. We report that, in addition to the choriocapillaris and retinal vasculature, VEGFR2 is expressed by adult photoreceptor cells and Muller cells. While systemic neutralization of VEGF in the mouse did not lead to detectable changes in retinal vascular perfusion or permeability, there was significant cell death in the INL and outer nuclear layer (ONL) as well as loss of visual function. A direct survival function for VEGF was demonstrated using a Muller cell line as well as primary photoreceptor cells and sheets. Taken together, these observations implicate VEGF in maintenance of the adult neural retina.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
VEGF and VEGFR2 expression in adult retina
###end title 14
###begin p 15
###xml 75 78 75 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 359 368 359 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1A</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Miquerol1">[28]</xref>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Ozerdem1">[29]</xref>
###xml 822 842 822 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1B arrowheads</xref>
###xml 940 955 940 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1B arrow</xref>
###xml 960 969 960 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s001">Figure S1</xref>
###xml 1235 1239 1235 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Bignami1">[30]</xref>
###xml 1339 1348 1339 1348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s001">Figure S1</xref>
###xml 1472 1475 1472 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Darland1">[2]</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 345 350 <span type="species:ncbi:10090">mouse</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
We have previously shown that VEGF is expressed by embryonic and adult RPE [3]. To examine VEGF expression patterns in adult eye, we used mice heterozygous for the LacZ reporter gene with a nuclear localization signal under the control of the VEGF promoter (28). Here we show that VEGF is also expressed by cells in the GCL and INL in the adult mouse retina (Figure 1A, arrowheads and asterisks, respectively). To determine the identity of the cells expressing VEGF in the GCL, flat-mounted retinas from adult VEGF-LacZ mice [28] were co-labeled for lac-Z and for NG2, the chondroitin sulfate proteoglycan, as a pericyte marker [29]. There were two distinct populations of Lac-Z positive cells. One was pericytes, identified by their expression of NG2 and their characteristic abluminal association with the microvessels (Figure 1B arrowheads). The second population of VEGF-expressing cells in the innermost retinal layer were astrocytes (Figure 1B arrow and Figure S1). In the retina, astrocytes are characterized by cell bodies that are located in the intercapillary spaces but with processes closely associated with the microvessels. Immunohistochemical localization of the astrocyte marker, glial fibrillary acidic protein (GFAP) [30], on VEGF-LacZ adult retina confirmed this second VEGF expressing cell population to be astrocytes (Figure S1). This pattern of VEGF expression in the GCL is consistent with our previous observations in postnatal retinal development [2].
###end p 15
###begin title 16
VEGF signaling in the adult retina.
###end title 16
###begin p 17
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-lacZ</italic>
###xml 417 428 417 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2-lacZ</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 1168 1171 <span type="species:ncbi:10116">rat</span>
###xml 1192 1195 <span type="species:ncbi:10116">rat</span>
###xml 1289 1294 <span type="species:ncbi:10090">mouse</span>
###xml 1361 1366 <span type="species:ncbi:10090">mouse</span>
(A) Sections of eyes from adult VEGF-lacZ mice stained for LacZ using x-gal (blue) revealed VEGF expression in the GCL (arrowheads) and INL layer (asterisks). (B) Flat-mounted retinas from adult VEGF-lacZ mice stained for lacZ (blue) and NG2 (brown) demonstrated VEGF expression by NG2-positive cells associated with microvessels (arrowhead) and by some astrocytes (arrow) in the GCL. (C) Sections of eyes from adult VEGFR2-lacZ mice stained for lacZ revealed expression of VEGFR2 in the GCL, in the INL (asterisks), and in the photoreceptors where a strong lacZ staining was observed in the inner segments (arrows). (D) Immunohistochemistry for VEGFR2 in sections of adult retina revealed expression in vascular cells (arrowhead), in Muller cells processes, and in the IS of the photoreceptors (arrows). (E) Immunohistochemistry for VEGFR1 revealed a spotty expression in the IPL and OPL. VEGFR1 was also detected in the photoreceptor IS. (F) Staining of Muller cells using CRALBP revealed an expression pattern similar to VEGFR2 (compare with D). (G) Expression of VEGF and its receptors, VEGFR1 and VEGFR2, by Muller cells was confirmed by RT-PCR of RNA from adult rat retina and isolated rat Muller cells. (H) Expression of VEGFR1 and VEGFR2 in photoreceptors (PR) isolated from adult mouse retinas. (I) Immunoprecipitation (IP) of VEGFR2 from pooled adult mouse retinas, followed by immunoblotting for phosphorylated tyrosine revealed VEGFR2 expression (bottom panel) and activation (top panel) in the adult retina. As a control, lysates of porcine aortic endothelial (PAE) cells overexpressing VEGFR2 either untreated or stimulated with VEGF were immunoprecipitated and immunoblotted as described above. GCL: ganglion cell layer, IPL: inner plexiform layer, INL: inner nuclear layer, OPL: outer plexiform layer, ONL: outer nuclear layer, IS: inner segment, OS: outer segment. Scale bar is 100 microm.
###end p 17
###begin p 18
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2</italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 206 222 206 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia Coli</italic>
###xml 222 226 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Shalaby1">[31]</xref>
###xml 311 331 308 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1D, arrowhead</xref>
###xml 400 417 397 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1C, arrows</xref>
###xml 557 566 554 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1D</xref>
###xml 639 659 636 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1D, arrowhead</xref>
###xml 783 787 780 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-BuntMilam1">[32]</xref>
###xml 789 798 786 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1F</xref>
###xml 1148 1157 1145 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1E</xref>
###xml 1587 1596 1584 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1H</xref>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 206 217 <span type="species:ncbi:562">Escherichia</span>
###xml 1176 1179 <span type="species:ncbi:10116">rat</span>
###xml 1565 1570 <span type="species:ncbi:10090">mouse</span>
To precisely identify the cellular targets of VEGF, we examined sections of retinas from heterozygous VEGFR2-lacZ mice where the 5' region of the VEGFR2 gene was replaced with a promoterless lacZ gene from Escherichia Coli[31]. beta-gal staining revealed that VEGFR2 was expressed by vascular cells in the GCL (Figure 1D, arrowhead) and INL as well as by the photoreceptors (ONL and inner segments) (Figure 1C, arrows). Consistent with the lac-Z staining, VEGFR2 expression, determined by immunochemistry, was observed throughout most of the neural retina (Figure 1D). Strong VEGFR2 immunoreactivity was noted in retinal microvasculature (Figure 1D, arrowhead). The comparison of VEGFR2 expression pattern with the Muller cell marker, cellular retinaldehyde binding-protein (CRALBP) [32] (Figure 1F), indicated expression of VEGFR2 by Muller cells. Muller cell nuclei are localized in the INL and they project processes that extend from the inner limiting membrane to the outer part of the ONL. Immunodetection of VEGFR1 revealed a punctuate staining of the inner and outer plexiform layers as well as of the inner segments (IS) of photoreceptors (Figure 1E). RT-PCR of adult rat retina and purified Muller cells revealed enrichment of RNA for VEGF as well as VEGFR1, VEGFR2 and neuropilin-1 (NP1) signals in Muller cells, suggesting that Muller cells are a significant source of VEGF and its receptors in the retina. The localization of VEGF receptors in the IS of the photoreceptors was confirmed by RT-PCR analysis of VEGFR1 and VEGFR2 on freshly isolated adult mouse photoreceptors (Figure 1H).
###end p 18
###begin p 19
###xml 311 320 311 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1I</xref>
Examination of the activation status of VEGFR2, the main signaling receptor for VEGF, was accomplished by immunopreciptation from pooled adult retina lysates, followed by immunoblotting for phosphorylated tyrosine. Results of this analysis indicated that VEGFR2 is constitutively activated in the adult retina (Figure 1I), an observation that is consistent with a role of VEGF in adult retina homeostasis.
###end p 19
###begin title 20
Systemic VEGF neutralization does not affect retinal vasculature
###end title 20
###begin p 21
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kendall1">[33]</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kamba1">[34]</xref>
###xml 637 646 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002">Figure 2A</xref>
###xml 843 858 843 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002">Figure 2B and C</xref>
###xml 1004 1013 1004 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s002">Figure S2</xref>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 779 783 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
To elucidate the function of VEGF in the adult retina, we neutralized VEGF systemically using an adenovirus expressing sFlt1 (Ad-sFlt1). sFlt1, a soluble form of VEGFR1 produced by alternative mRNA splicing, is a potent VEGF inhibitor [33]. As prior reports indicate a role for VEGF in maintenance of the microvasculature of various organs, including the trachea, pancreas and thyroid [34], we first sought to determine if systemic sFlt1-expression led to any changes in retinal vessels. Examination of retinal flat mounts from fluorescein-perfused mice expressing-sFlt1 for 14 days revealed no gross changes in the retinal vasculature (Figure 2A). Collagen IV immunostaining of retinal sections from fluorescein-dextran perfused mice revealed normal perfusion in the retinas of mice that had expressed sFlt1 for 14 days compared to controls (Figure 2B and C). NG2 staining of retinal flat mounts from sFlt1-expressing mice showed no apparent changes in pericyte association to the retinal microvessels (Figure S2).
###end p 21
###begin title 22
VEGF neutralization does not affect retinal vascular perfusion or permeability.
###end title 22
###begin p 23
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
###xml 516 520 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
###xml 1238 1242 <span type="species:ncbi:10090">mice</span>
Mice infected with Ad-null or Ad-sFlt1 for 14 days were perfused with h.m.w fluorescein dextran (green), then eyes were dissected and (A) flat mounted or (B) sectioned and immunostained for collagen IV, and visualized with a Cy3-conjugated secondary antibody (red). (A) Flat mounts of retinas from mice expressing sFlt1 perfused with fluorescein dextran shows no gross abnormalities or perfusion defects, and no changes in capillary density in the inner retina compared to the control mice expressing Ad-null (n = 6 mice/condition). (B) Immunofluorescent localization of collagen IV in sections of fluorescein-perfused retinas revealed nearly complete overlay of FITC-dextran and collagen IV of the inner retinal vessels in both Ad-null and Ad-sFlt1 (arrows, third column). (C) Quantification of fluorescein- and collagen IV-positive vessels of the innermost retinal vasculature in Ad-sFlt1 (n = 5) compared to Ad-null (n = 4) showed no reduction in the number of perfused vessels, indicating the absence of vascular damage. (D) Fluorescein angiography of experimental mice seven days after infection showing no opacity in the vitreous 4-5 min after injection in either group, indicating no change in retinal vascular permeability (n = 6 mice/condition). Scale bar is 1 mm in A and 100 microm in B.
###end p 23
###begin p 24
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Venkatesha1">[35]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj1">[20]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Erickson1">[36]</xref>
###xml 601 610 601 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g002">Figure 2D</xref>
###xml 781 796 781 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003">Figure 3A and B</xref>
###xml 993 1002 993 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003">Figure 3A</xref>
###xml 144 148 <span type="species:ncbi:10116">rats</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
As it has been previously shown that systemic neutralization of VEGF leads to increased permeability in the lung and kidney of sFlt1-expressing rats [35] and in the brain of sFlt1-expressing mice [20], we sought to determine if systemic VEGF neutralization would affect the permeability of the retinal vasculature. The vessels of the retinal vasculature have properties similar to the blood brain barrier, and as such, are relatively impermeable [36]. Fluorescein angiography of the retina demonstrated no differences in fluorescein leakage between mice expressing Ad-null or Ad-sFlt1 for seven days (Figure 2D). Transmission electron microscopic examination of the retinal vasculature did not reveal structural alterations in the inner retina capillaries or the choriocapillaris (Figure 3A and B). The capillaries of the GCL of sFlt1-expressing mice displayed normal morphology with well-defined extracellular space and basement membrane, few cytoplasmic vacuoles and normal tight junctions (Figure 3A).
###end p 24
###begin title 25
Systemic VEGF blockade does not alter retinal vessels ultrastructure or choriocapillaris fenestration.
###end title 25
###begin p 26
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
(A) TEM of a microvessel located in the GCL of sFlt1 expressing mouse at day 14 showed a normal ultrastructure of the endothelial nuclei and cytoplasm. Characteristically electron -dense tight junctions were well defined (arrows). (B) TEM micrograph of the outer segment of a retina, 14 days post-infection of Ad-sFlt1, revealed a normal RPE-choroid complex. The RPE basal infoldings were dense and well associated with the Bruch's membrane (BM). The choriocapillaris showed no thickening of the membrane. No sign of thrombosis were detected. (C) Higher magnification of the choriocapillaris revealed numerous fenestrations on the endothelial membrane facing the RPE (arrows). (D) Endothelial fenestrations of the choriocapillaris (arrows) were quantified at 28 days post-infection on TEM micrographs (n = 3 mice/condition). No change in the number of choriocapillaris fenestration was observed between Ad-null and Ad-sFlt1 mice. Scale bar is 5 microm in A-B, 0.5 microm in C and 1 microm in D.
###end p 26
###begin p 27
###xml 243 252 243 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003">Figure 3B</xref>
###xml 329 338 329 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003">Figure 3C</xref>
###xml 531 540 531 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g003">Figure 3D</xref>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
Similarly, there were no structural abnormalities of the RPE-choriocapillaris complex. The Bruch's membrane of sFlt1-expressing mice appeared normal with well defined layers and no apparent thickening. No sign of thrombosis could be detected (Figure 3B). The choriocapillaris retained their characteristic fenestrated phenotype (Figure 3C). Electron microscopic quantification of fenestrations in the choriocapillaris endothelium of mice expressing sFlt1 for 28 days showed no difference compared to the Ad-null infected controls (Figure 3D).
###end p 27
###begin title 28
VEGF neutralization leads to neuroretinal cell apoptosis and loss of retinal function
###end title 28
###begin p 29
###xml 131 142 131 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g004">Figure 4A&#8211;B</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Lewis1">[37]</xref>
###xml 361 370 361 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s003">Figure S3</xref>
###xml 575 584 575 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5A</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
Examination of retinal cryosections from mice expressing sFlt1 for 14 days revealed significant apoptosis in both the INL and ONL (Figure 4A-B). Retinal damage is generally associated with Muller cell activation that is marked by upregulation of GFAP [37]. However, there was no increase in GFAP expression in Muller cells of mice expressing sFlt1 for 14 days (Figure S3), suggesting that the observed cell death is not the consequence of any ongoing retinal injury. The increased cell death resulted in a significant reduction in the thickness of the INL and ONL by day 28 (Figure 5A).
###end p 29
###begin title 30
VEGF neutralization leads to increased retina cell death.
###end title 30
###begin p 31
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
(A) TUNEL staining showed markedly increased apoptosis in both the INL and ONL of Ad-sFlt1 mice 14 days post-infection (n = 4 mice/condition). (B) Higher magnification images of retinal sections of sFlt1-expressing mice stained for TUNEL and counterstained with hematoxylin revealed an significant increase in the number of apoptotic cells in the INL and ONL. GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer, OPL: outer plexiform layer, Ch: choroid. Scale bars are 100 microm in A and 50 microm in B.
###end p 31
###begin title 32
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Decreased retina thickness and loss of visual function in sFlt1 expressing mice.
###end title 32
###begin p 33
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
(A) Semi-thin epon sections from retinas of experimental mice expressing sFlt1 for 28 days showed substantial thinning of the INL (black double arrowheads line) and the ONL (white double arrowheads line) (n = 3 for Ad-null and n = 4 for Ad-sFlt1). (B-D) TEM of retinas from sFlt1 expressing mice at 28 days. (B-C) Micrographs taken in the INL region revealed apoptotic Muller cells (MC) and amacrine cells (A). Both cells displayed condensation of the chromatin, membrane swelling and rupture mitochondria (arrows). (D) In the ONL, a high percentage of photoreceptors appeared apoptotic (white asterisk). Cell death left numerous empty spaces containing membranous debris (arrowhead). Processes from the Muller cells that normally fill the intercellular space appeared shrunken (MP). (E) Scotopic ERG recordings of experimental mice 28 days post-infection using a flash intensity of +10 dB revealed a marked reduction of both a- and b-wave amplitudes in sFlt1-expressing mice (n = 6 for Ad-null and n = 10 for Ad-sFlt1). GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer, OPL: outer plexiform layer, Ch: choroid. Scale bars are 100 microm in A and 5 microm in B to D.
###end p 33
###begin p 34
###xml 265 274 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5B</xref>
###xml 296 305 296 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5C</xref>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Jeon1">[38]</xref>
###xml 478 493 478 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5B and C</xref>
###xml 647 656 647 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5D</xref>
###xml 865 874 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5D</xref>
The INL is comprised primarily of Muller and neural cells, including bipolar, horizontal and amacrine cells, whereas the ONL contains photoreceptor cell bodies. Electron micrographs revealed typical signs of apoptosis in various cells of the INL. Apoptotic Muller (Figure 5B) and amacrine cells (Figure 5C) could be identified based on their location and morphological characteristics [38]. Both cells showed chromatin condensation, membrane swelling and ruptured mitochondria (Figure 5B and C). Cell death was even more evident in the ONL where a high number of photoreceptor cell bodies displayed cellular shrinkage, and chromatin condensation (Figure 5D). The combination of photoreceptor cell death and retraction of Muller cells processes (MP), which are normally closely associated with the photoreceptors, left large empty spaces containing cellular debris (Figure 5D).
###end p 34
###begin p 35
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Pinto1">[39]</xref>
###xml 338 347 338 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g005">Figure 5E</xref>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Visual dysfunction resulting from the increased cell death observed in sFlt1 expressing mice was assessed using electroretinogram (ERG) recordings. The ERG results from the electric current created by light-induced activity of neuronal and glial cells [39]. ERG recording revealed a significant reduction of both a- and b-wave amplitude (Figure 5E). Reduction of more than half of the a-wave amplitude is indicative of a considerable loss of photoreceptor function and is consistent with our previous observations. The reduction of the b-wave is a sign of an altered photoreceptor post-synaptic cascade that reflects the increase in photoreceptor apoptosis. A possible contribution of bipolar cell dysfunction to the reduced b-wave could not be excluded.
###end p 35
###begin title 36
Autocrine VEGF signaling plays a role in Muller cell survival
###end title 36
###begin p 37
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Limb1">[40]</xref>
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6A</xref>
###xml 796 805 792 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6B</xref>
###xml 931 940 927 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6C</xref>
###xml 1119 1128 1115 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6D</xref>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
In light of the co-expression of VEGF and its receptors by Muller cells, we investigated whether the disruption of a VEGF autocrine pathway on Muller cells was mediating the increased cell death in the INL of sFlt1 expressing mice. Because of the technical difficulty to isolate sufficient numbers of differentiated Muller cells, we used the Muller cell line, MIO-M1. MIO-M1 is a spontaneously immortalized human Muller cell line that retains most of the characteristic Muller cell morphology, protein expression and function [40]. We used siRNA mRNA to alter autocrine VEGF signaling by inhibiting its autonomous expression. Transfection of siVEGF led to a 76% decrease in VEGF mRNA (Figure 6A) and a 94% reduction of secreted VEGF protein (from 1.63 ng/ml+/-0.01 to 0.1 ng/ml+/-0.01) at day 3 (Figure 6B). Inhibition of VEGF expression under serum-free conditions led to an increase in the number of TUNEL-positive MIO-M1 cells (Figure 6C). Quantification of apoptosis by FACS analysis revealed a doubling in the number of apoptotic cells in siVEGF-transfected cells compared to cells transfected with control siRNA (Figure 6D).
###end p 37
###begin title 38
Inhibition of the autocrine VEGF signaling in Muller cells leads to increased cell death.
###end title 38
###begin p 39
###xml 814 817 814 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bax</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
VEGF expression by MIO-M1 Muller cells was inhibited by transfection of siRNA into sub-confluent cells. (A-B) Seventy-two hr following transfection of the control and VEGF siRNA, VEGF mRNA levels were determined by qPCR (A) and VEGF protein secretion was quantified by ELISA (B). siVEGF transfection led to a 75% inhibition of VEGF mRNA and more than 90% reduction of VEGF protein (n = 3). (C) Inhibition of VEGF was associated with an increase in TUNEL-positive cells after three days of culture in serum-free conditions (n = 4). (D) Quantification of cell death by FACS analysis demonstrated a doubling of the number of annexin-V positive apoptotic cells in siVEGF transfected cells compared to siControl (n = 3). (E) Increased apoptosis was accompanied by a significant up-regulation of the pro-apoptotic gene, bax, and by the increase of the Bax/Bcl-2 ratio (F). Scale bar is 100 microm.
###end p 39
###begin p 40
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Gross1">[41]</xref>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
###xml 342 347 342 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 357 358 357 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 352 358 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
###xml 487 496 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6E</xref>
###xml 540 549 540 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax/Bcl-2</italic>
###xml 568 577 568 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g006">Figure 6F</xref>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 621 622 621 622 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 616 622 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
Apoptosis is tightly controlled by the balance between pro- and anti-apoptotic genes of the Bcl-2 family. Changes in the relative expression of the Bcl-2 family members in favor of pro-angiogenic genes will ultimately decide cell fate [41]. Therefore, we determined the expression level of the pro-apoptotic gene Bax and anti-apoptotic genes Bcl-2 and Bcl-xL by quantitative PCR. Inhibition of VEGF expression by MIO-M1 cells resulted in the up-regulation of the pro-apoptotic gene Bax (Figure 6E), leading to a significant increase in the Bax/Bcl-2 expression ratio (Figure 6F). No significant changes in Bcl-2 and Bcl-xL expression were detected (data not shown).
###end p 40
###begin title 41
VEGF is a direct survival factor for photoreceptors
###end title 41
###begin p 42
###xml 286 295 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s004">Figure S4</xref>
###xml 466 475 466 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s005">Figure S5</xref>
###xml 589 598 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7A</xref>
###xml 811 820 811 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7B</xref>
###xml 1244 1255 1240 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g007">Figure 7C&#8211;D</xref>
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Based on our observation that photoreceptors express VEGF receptors, we used freshly isolated post-mitotic mouse photoreceptors to determine if VEGF could directly influence photoreceptor survival. Photoreceptor sheets were isolated by mechanical fractionation of flat-mounted retinas (Figure S4). Purity of the preparation was controlled by co-immunodetection of the photoreceptor marker, recoverin, and the Muller cell markers, GFAP and glutamine synthetase (GS) (Figure S5). Isolated photoreceptor cells cultured in absence of serum died rapidly (as measured by Trypan blue exclusion) (Figure 7A). However, the addition of 10 ng/ml of VEGF165 was sufficient to rescue the photoreceptors, so that at 72 hr there were only 8.2% apoptotic cells in the presence of VEGF compared to 37.4% in the absence of VEGF (Figure 7B). This pro-survival function of VEGF was confirmed using photoreceptor explants in which 60 microm sections containing only the photoreceptor cell bodies and their inner segments were cultured in presence or absence of VEGF165. As observed with isolated photoreceptor cells, the absence of serum resulted in a time-dependent increase in apoptosis while the addition of VEGF led to significant protection against apoptosis (Figure 7C-D).
###end p 42
###begin title 43
VEGF is a direct survival factor for photoreceptors.
###end title 43
###begin p 44
###xml 48 52 <span type="species:ncbi:10090">mice</span>
(A) Photoreceptors isolated from adult C57BL/6J mice were cultured on laminin-coated wells in absence or presence of 10 ng/ml VEGF165 for up to 72 hr. Addition of 10 ng/ml of VEGF165 decreased the number of dead cells identified by trypan blue staining. (B) Quantification of the percentage of dead photoreceptors based on the trypan blue exclusion assay revealed a significant protection from apoptosis by VEGF165 (n = 9). (C) ONL explants containing only the photoreceptor nuclei and IS were cultured in basal medium+/-10 ng/ml of VEGF165 for 24, 48 and 72 hr. Apoptotic cells were detected by TUNEL staining. (D) Quantification of TUNEL-positive cells per sheet revealed a significant decreased in the number of apoptotic photoreceptors in presence of VEGF (n = 6).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-DAmore1">[18]</xref>
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kim1">[14]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Gilbert1">[42]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Nishijima1">[43]</xref>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Gerhardinger1">[44]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Nishijima1">[43]</xref>
###xml 493 497 493 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Stitt1">[45]</xref>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 1119 1123 <span type="species:ncbi:10090">mice</span>
There is growing evidence that VEGF effects are not specific to the vasculature. A variety of non-vascular cells express VEGFR2, the primary VEGF signaling receptor, and VEGF has been shown to act on these cells to mediate proliferation, differentiation and/or survival (for review see [18]). Previous studies reported the expression of VEGFR2 by glial and neuronal cells of the retina [14], [42], [43], [44] but VEGFR2 expression by photoreceptors has not been definitively established [43], [45]. The combined use of VEGFR2-LacZ mice and immunohistochemistry for VEGFR2 allow us to unequivocally demonstrate the expression of VEGFR2 on Muller cells and photoreceptors. The wide expression of VEGF and VEGFR2 in adult retina and the finding that VEGFR2 is constitutively phosphorylated strongly indicates a role for VEGF signaling in retina homeostasis. We therefore elected to assess the role of VEGF in the normal retina by systemic neutralization. Systemic blockade was selected over intravitreal injection because these studies are intended to assess the effect of sustained and long-term VEGF inhibition in adult mice.
###end p 46
###begin p 47
###xml 217 224 217 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Fragoso1">[46]</xref>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Mercurio1">[47]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Guan1">[48]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Bryan1">[49]</xref>
###xml 574 578 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj2">[50]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Lee1">[51]</xref>
###xml 594 597 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 692 699 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Lee1">[51]</xref>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
The observation that Muller cells, which express both VEGF as well as its receptors, VEGFR1 and VEGFR2, undergo apoptosis in mice with systemic VEGF neutralization suggested an autocrine role for VEGF in Muller cells in vivo. This concept is strongly supported by the finding that siRNA suppression of VEGF expression in cultured Muller cells leads to a significant increase in cell death. Co-expression of VEGF and VEGFR2 has been observed in many tumor cells [46], [47] but only in a few normal cell types, such as podocytes [48], skeletal muscle [49], aortic endothelium [50], [51], and RPE [3]. However, a role for VEGF autocrine pathways in tissue homeostasis has only been demonstrated in vivo in the endothelium, where cell-autonomous signaling of VEGF appears to be required for endothelial cell survival [51].
###end p 47
###begin p 48
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
###xml 236 241 236 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-2</italic>
###xml 251 252 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bcl-x<sub>L</sub></italic>
###xml 313 316 313 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Culmsee1">[52]</xref>
###xml 535 538 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bax</italic>
Our data showed that VEGF autocrine signaling promotes Muller cell survival in serum-free conditions through the control of pro-apoptotic Bax gene expression. Interestingly, no changes in the level of expression of anti-apoptotic genes Bcl-2 and Bcl-xL were observed after alteration of VEGF autocrine signaling. Bax constitutes one of the main transcriptional targets of p53 in neuronal and glial cells [52] suggesting that VEGF autocrine signaling regulates Muller cell apoptosis through the control of p53 expression/activation and Bax expression.
###end p 48
###begin p 49
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Newman1">[53]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Seki1">[54]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Carmignoto1">[55]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Vecino1">[56]</xref>
###xml 995 998 995 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 1258 1261 1258 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Marneros1">[4]</xref>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Garcia1">[57]</xref>
###xml 1443 1447 1443 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Nishijima1">[43]</xref>
###xml 1641 1645 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Nishijima1">[43]</xref>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 1614 1617 <span type="species:ncbi:10116">rat</span>
The physical association between the photoreceptors that express VEGFR2 and the Muller cells that express VEGF points to a paracrine interaction in which Muller cells provide VEGF as a neurotrophic signal to photoreceptors. The dramatic increase in apoptosis associated with visual dysfunction observed in mice expressing sFlt1 is consistent with this suggestion. Using purified photoreceptors, we were able to demonstrate a direct function of VEGF on photoreceptor survival independent of an effect on accessory cells. Muller cells act to support retinal neurons by providing structural support for the retina and regulating ion and neurotransmitter levels in the extracellular space [53]. In addition, they produce a variety of neurotrophic factors, including brain-derived neurotrophic factor (BDNF) [54], nerve growth factor (NGF) [55] and neurotrophins (NT-3 and NT-4/5) [56]. Our findings add VEGF to this list. Though retinal pigment epithelial cells (RPE) also produce VEGF in the adult [3], they are unlikely to be a primary source of VEGF for the photoreceptors because of their distance from the photoreceptor cell bodies. Moreover, RPE have been shown to secrete VEGF basally, presumably in support of the underlying fenestrated choriocapillaris [4]. In addition to supporting photoreceptors, Muller cells have been to shown to maintain adult retinal ganglion cell (RGC) survival in vitro [57] and the fact that RGC express VEGFR2 [43] suggests that Muller cell-derived VEGF also plays a supporting role for RGCs. In support of this, it has been demonstrated that long-term VEGF (8 wk) blockade in the rat leads to RGC apoptosis [43].
###end p 49
###begin p 50
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Garcia2">[58]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Isenmann1">[59]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Linsenmeier1">[60]</xref>
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Shweiki1">[61]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Stein1">[62]</xref>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Zachary1">[63]</xref>
###xml 940 944 940 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Sondell1">[64]</xref>
The requirement of glial and neuronal cells for VEGF as a survival factor under normal conditions is one of the most intriguing findings of our study. Muller cells and neurons produce numerous neurotrophic factors to support the retina [58], [59]. Dependence on VEGF signaling may be due to the high metabolic rates of retinal neurons and their extreme sensitivity to hypoxia [60]. As VEGF expression is tightly controlled by oxygen tension and glycemia level [61], [62], VEGF would be the ideal candidate to support retina homeostasis during the early phase of an oxidative or ischemic insult. Indeed, VEGF has been shown to protect neuronal cells of the central nervous system (CNS) against apoptosis induced by serum deprivation or hypoxia [63]. The VEGF-dependent paracrine relationship between the Muller cell and photoreceptors that we have revealed here parallels the trophic association between Schwann cells and neurons in the CNS [64].
###end p 50
###begin p 51
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj2">[50]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Ng1">[65]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kamba1">[34]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj2">[50]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kamba1">[34]</xref>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj2">[50]</xref>
###xml 737 745 737 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 750 757 750 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Roberts1">[66]</xref>
###xml 763 767 763 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Yokomori1">[67]</xref>
###xml 1174 1178 1174 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Peters1">[68]</xref>
We have previously observed VEGF expression in virtually all vascularized adult tissues [50], [65] and we and others have hypothesized that VEGF plays an important role in the maintenance of the adult vasculature [34], [50]. In support of this, relatively short-term systemic VEGF neutralization has been shown to lead to the selective regression of some fenestrated microvessels [34], leading to the hypothesis that these fenestrated vessels are particularly dependent on VEGF for their survival. In fact, we have shown that nearly all fenestrated vessels, including for example the glomerulus of the kidney and the chroroid plexus in the brain, lie in close proximity to epithelial cells that express high levels of VEGF [50]. Studies in vitro and in vivo[66], [67] have demonstrated that ectopic application of VEGF can induce the formation of fenestrations. Interestingly, our analysis did not reveal an effect of systemic VEGF neutralization on the fenestrations of the choriocapillaris. A recent report in which intravitreal administration of Avastin in a primate model led to early loss of fenestration with rapid recovery in spite of the prolonged Avastin half-life [68], leads us to speculate that the loss of fenestrations is a transient effect that one might not expect to be detectable at this later (28 days post infection) time point.
###end p 51
###begin p 52
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj2">[50]</xref>
###xml 592 596 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kamba1">[34]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Engerman1">[69]</xref>
###xml 1190 1194 1190 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-AntonelliOrlidge1">[70]</xref>
###xml 1196 1200 1196 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Hirschi1">[71]</xref>
###xml 1292 1296 1292 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Cogan1">[72]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Cogan2">[73]</xref>
###xml 1399 1408 1399 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003554-g001">Figure 1D</xref>
###xml 1427 1430 1427 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Darland1">[2]</xref>
Our observation of relatively low levels of VEGF in the innermost retinal layers and the fact that systemic VEGF expression does not influence the inner retinal vasculature, which is not fenestrated but is the site of the blood neural barrier, are consistent with the idea that high local VEGF levels reflect a particular dependence on VEGF, which renders them particularly sensitive to systemic VEGF blockade. Consistent with this notion, the microvasculature of the brain, which has relatively low levels of VEGF in the adult [50], was not influenced by 14 days of systemic VEGF inhibition [34]. In addition to the relatively low levels of local VEGF, the microvasculatures of the retina and brain are characterized by high ratio of pericyte to endothelial cells [69]. In light of the evidence that pericyte association with EC mediates vessel stabilization, it is reasonable to suggest that the microvasculature of the CNS is particularly stable. On the other hand, it is difficult to evaluate the extent of VEGF neutralization at the level of the retinal microvasculature by systemically expression of sFlt1. Based on our previous extensive use of endothelial cell-pericytes cocultures [70], [71] and the documented close association between endothelial cells and pericytes in the retina [72], [73], we suspect that the VEGF produced by pericytes to support retinal capillary endothelial cells (Figure 1D in this paper and [2]) may be relatively less accessible to soluble Flt-1 and thus may account for the lack of an effect of VEGF neutralization on the inner retinal vessels in the time frame of this study.
###end p 52
###begin p 53
###xml 673 677 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Ramsauer1">[74]</xref>
###xml 679 683 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Darland2">[75]</xref>
###xml 702 706 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Uemura1">[76]</xref>
Our results have obvious implications for therapeutic use of anti-VEGF, particularly as it relates to the eye, as we observed that VEGF neutralization interferes with endogenous survival signals, leading to unexpected neural toxicity. On the other hand, however, since the adult retina expresses VEGF in the absence of active neovascularization, it is clear that the locally produced VEGF mediates neural protection without leading to vessel permeability or growth. The absence of active vessel proliferation/permeability in the normal retina in the presence of endogenous VEGF may be due to the dose, localization and/or the presence of opposing factors, such as TGF-beta [74], [75] or angiopoietin-1 [76]. However, it does indicate that, with appropriate delivery and/or dosing, VEGF may find use as a neural survival factor for degenerative retinal pathologies.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Animals
###end title 55
###begin p 56
###xml 6 15 6 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-lacZ</italic>
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Miquerol1">[28]</xref>
###xml 87 98 87 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2-lacZ</italic>
###xml 104 108 104 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Shalaby1">[31]</xref>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 485 492 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8743;10</sup>
###xml 547 553 543 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8743;9</sup>
###xml 628 632 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maynard1">[25]</xref>
###xml 634 638 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Kuo1">[77]</xref>
###xml 16 20 <span type="species:ncbi:10090">mice</span>
###xml 99 103 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 407 411 <span type="species:ncbi:10090">mice</span>
###xml 519 522 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 562 565 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 573 579 <span type="species:ncbi:10090">murine</span>
###xml 718 721 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 734 737 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
Adult VEGF-lacZ mice (from Andreas Nagy, University of Toronto, Canada) [28] and adult VEGFR2-lacZ mice [31] (generous gift of Victoria Bautch, UNC-Chapel Hill, NC) were used for localization of VEGF and VEGFR2, respectively. Adult C57BL/6J mice were used for analysis of VEGFR expression and subsequent VEGF-induced photoreceptor survival (JAX Laboratories). For in vivo neutralization of VEGF, adult CD-1 mice 6-8 weeks old (Charles River Laboratories) were injected with either 1x10wedge10 viral particles (V.P.) Ad-CMV-null (control) or 2.5x10wedge9 V.P. Ad-CMV-sFlt1 (murine form consisting of the first three IgG repeats) [25], [77](Q.Biogene) on day 0. sFlt1 expression was confirmed by ELISA (R&D Systems). Ad-CMV-null and Ad-CMV-sFlt1 did not contain an Ig Fc region. Absence of systemic immune response was confirmed by the absence of leukocyte and platelet activation (data not shown). Circulating levels of sFlt1 of approximately200 ng/ml were measured on the plasma fraction seven days post-infection and were sustained for at least 21 days. Ad-null infected mice showed no detectable sFlt1. All animal protocols were approved by the Schepens Eye Research IACUC.
###end p 56
###begin title 57
Fluorescein-dextran perfusion
###end title 57
###begin p 58
###xml 79 85 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8743;6</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Anesthetized mice were perfused through the aorta with fluorescein dextran 2x10wedge6 m.w. (Sigma) 50 mg/ml in 4% paraformaldehyde in PBS. Eyes were then removed, fixed in 4% paraformaldehyde at 4degreesC overnight and processed for flat-mount and cryosections.
###end p 58
###begin title 59
Immunohistochemistry
###end title 59
###begin p 60
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF-lacZ</italic>
###xml 18 29 18 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGFR2-lacZ</italic>
###xml 426 430 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Brekken1">[78]</xref>
###xml 432 436 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Feng1">[79]</xref>
###xml 1047 1070 1038 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Griffonia simplicifolia</italic>
###xml 301 307 <span type="species:ncbi:9986">rabbit</span>
###xml 313 318 <span type="species:ncbi:10090">mouse</span>
###xml 470 476 <span type="species:ncbi:9986">rabbit</span>
###xml 510 516 <span type="species:ncbi:9986">rabbit</span>
###xml 577 583 <span type="species:ncbi:9986">rabbit</span>
###xml 622 628 <span type="species:ncbi:9986">rabbit</span>
###xml 689 695 <span type="species:ncbi:9986">rabbit</span>
###xml 778 784 <span type="species:ncbi:9986">rabbit</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 1047 1070 <span type="species:ncbi:3850">Griffonia simplicifolia</span>
###xml 1170 1176 <span type="species:ncbi:9986">rabbit</span>
###xml 1180 1185 <span type="species:ncbi:10090">mouse</span>
For VEGF-lacZ and VEGFR2-lacZ staining, sections and flat-mounted retinas were stained for LacZ using the in situ beta-galactosidase kit, according to the manufacturer's instructions (Stratagene). Flat-mounted retina, cryosections and photoreceptor explants were incubated overnight at 4degreesC with rabbit anti-mouse VEGFR2 T1014 (1:500, a gift from Dr. Brekken, University of Texas Southwestern Medical Center, Dallas, TX) [78], [79], mAb anti-CRALBP (1:500, Abcam), rabbit anti-VEGFR1 (1:100; Santa Cruz), rabbit anti-GFAP (1:300, Sigma), mAb anti-GFAP (1:250, Millipore), rabbit anti-collagen type IV (1:400, Abcam), rabbit anti-NG2 (1:300; Millipore), mAb anti-GS (1:250, Chemicon), rabbit anti-recoverin (1:500, Chemicon). Secondary antibodies included biotinylated anti-rabbit or anti-mouse antibodies (Vector Laboratories) and Cy5-, Cy3- or FITC-conjugated antibody (Jackson ImmunoResearch Laboratories). Some antibodies were visualized using 3, 3'-diaminobenzidine (ABC kit; Vector Laboratories). ECs were detected using FITC-conjugated Griffonia simplicifolia isolectin B4 (Vector Laboratories). Cell nuclei were identified by DAPI labeling. Incubation using rabbit or mouse IgG as a primary antibody was conducted as a negative control.
###end p 60
###begin title 61
Quantification of retinal vessel perfusion
###end title 61
###begin p 62
Retinal vascular perfusion was measured by comparing the number of type IV collagen-positive vessels of the inner retina (GCL) to the number of FITC positive vessels on 3 serial cryosections separated by 150 microm.
###end p 62
###begin title 63
Histology and electron microscopy
###end title 63
###begin p 64
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Maharaj1">[20]</xref>
Tissues were prepared for TEM as previously described [20]. Ultrathin sections were treated with uranyl acetate and visualized using a Phillips 410 transmission electron microscope.
###end p 64
###begin title 65
Quantification of INL and ONL thickness
###end title 65
###begin p 66
Semi-thin sections were cut along the vertical meridian passing through the optic nerve and stained with Richardson's stain for light microscopy. Three serial sections (100 microm apart) were quantified per animal. On each section, photographs were taken at 600 microm and 1800 microm from the optic nerve on each side. Three measurements were made per photographs. For each animal, the ONL and INL thickness was obtained by averaging all 36 measurements.
###end p 66
###begin title 67
Quantification of choriocapillaris fenestrations
###end title 67
###begin p 68
Endothelial fenestrations were quantified from electron micrographs of the peripheral region of the RPE-choroid (approximately 800 microm from the optic nerve) at a magnification of 10,400x. Only the RPE-side vessel wall was taken into consideration. Fenestrations were counted on 13-15 fields showing continuous choriocapillaris lumen with a length of 10 microm each.
###end p 68
###begin title 69
VEGFR2 activation status
###end title 69
###begin p 70
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-SaintGeniez2">[3]</xref>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
###xml 266 271 <span type="species:ncbi:9606">human</span>
Adult mouse retinas were dissected, pooled, lysed, and protein concentration was determined using a BCA assay (BioRad). VEGFR2 immunoprecipitation and phospho-tyrosine blot was performed as previously described [3]. As a control, porcine aortic cells overexpressing human VEGFR2 (PAE-VEGFR2) were serum-starved overnight and incubated with 50 ng/mlVEGF165 (R&D Systems) for five min. Lysates were then collected and used for immunoprecipitation.
###end p 70
###begin title 71
Fluorescein angiography
###end title 71
###begin p 72
Fluorescein angiography was performed after intraperitoneal injection of 60 mg/kg of 25% fluorescein sodium (Akorn). Photographs were taken using the Topcon/Imagenet system (Topcon Medical System) with a preset 20D lens apposed to the fundus camera at regular time intervals (from 1 min to 4 min post I.P injection). Fluorescein leakage was noted as diffuse opacity in the vitreous over-time.
###end p 72
###begin title 73
TUNEL assay
###end title 73
###begin p 74
Apoptotic cells were detected using the Dead End HRP kit (Promega) or the Roche In Situ Cell Death Detection TMR red kit (Roche Diagnostic) following the manufacturer's instructions.
###end p 74
###begin title 75
Electroretinography
###end title 75
###begin p 76
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
Mouse ERG was assessed 28 days post adenovirus infection on dark-adapted mice using a UTAS-E3000 recording system (LKC, Technologies, Inc.). After pupil dilatation with 1% tropicamide, 1.5% cyclopentolate, each mouse was placed in front of a Ganzfeld bowl (UTAS3000; LKC Technologies). ERG responses to a series of increasing-intensity light flashes: +/-0, +10 and +20-dB were averaged over 10 separate flashes per light intensity.
###end p 76
###begin title 77
Cell culture
###end title 77
###begin p 78
###xml 174 175 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 358 364 <span type="species:ncbi:9913">bovine</span>
The human Muller cell line, MIO-M1 (a gift from G.A. Limb, Institute of Ophthalmology and Moorfields Eye Hospital, London, UK), was maintained in culture at 37degreesC, 5% CO2 in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen Gibco) supplemented with 2 mmol/L glutamine, 100 IU/ml penicillin, 100 microg/ml streptomycin (all from Gibco) and 10% fetal bovine serum (Sigma). Cells were used from passage P16 to P25. MIO-M1 apoptosis was quantified using the Vybrant Apoptosis Assay #2 (Molecular Probes) followed by flow cytometry using a FACSCAN flow cytometer.
###end p 78
###begin title 79
siRNA mediated gene silencing of VEGF
###end title 79
###begin p 80
###xml 392 397 <span type="species:ncbi:9606">human</span>
Inhibition of VEGF expression was achieved using an ON-TARGETplus SMARTpool containing four pooled siRNA duplexes (Dharmacon). An unrelated control siRNA pool that lacks identity with known gene targets was used as a control for non-sequence-specific effects. MIO-M1 cells were transfected with siRNA using Dharmafect 1. VEGF in the cell culture supernatant was determined using a Quantikine human VEGF Immunoassay kit (R&D Systems).
###end p 80
###begin title 81
Reverse Transcription-PCR Analysis
###end title 81
###begin p 82
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Gerhardinger2">[80]</xref>
###xml 446 453 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003554-t001">Table 1</xref>
###xml 659 666 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003554-t002">Table 2</xref>
###xml 55 58 <span type="species:ncbi:7460">Bee</span>
###xml 133 136 <span type="species:ncbi:10116">rat</span>
Total RNA was isolated from tissue and cells using RNA-Bee solution (IsoText Diagnostic Inc.). Muller cells were isolated from adult rat retinas by density gradient centrifugation as described previously [80] and total RNA isolated using the RNEasy kit (Quiagen). RNA was reverse-transcribed using Superscript III (Invitrogen). Standard PCR was performed with 1 U Taq DNA polymerase (Roche Diagnostics) and 0.2 microM of appropriate primer pair (Table 1). qPCR reactions were performed using the SYBR Green Master mix and the ABI Prism 9700 Sequence Detection System (Applied Biosystems) according to the manufacturer's instructions. For primer sequence, see Table 2.
###end p 82
###begin title 83
RT-PCR primers.
###end title 83
###begin title 84
qPCR primers.
###end title 84
###begin title 85
Isolation of photoreceptor sheets
###end title 85
###begin p 86
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-Fontaine1">[81]</xref>
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003554-MohandSaid1">[82]</xref>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
Sheets of photoreceptors were isolated from adult C57BL/6J mice as described previously [81], [82]. Retinas from 6-8 week old C57BL/6J mice were dissected and flattened by making 4 radial cuts, then placed on a 20% gelatin block secured to a vibratome chuck. Starting at the vitreal surface, sequential sections were cut until the photoreceptor layer was reached then a 200 microm thick section, containing the ONL and IS, was collected. In some experiments the 60 microm thick sections were cultured as ONL explants in the presence or absence of 10 ng/ml VEGF165 (R&D Systems) and apoptotic cells per section were quantified by TUNEL assay.
###end p 86
###begin title 87
Trypan blue exclusion assay
###end title 87
###begin p 88
###xml 185 186 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Photoreceptor cells collected by enzymatic digestion (papain) of vibratome-isolated photoreceptor sheets were cultured in 96 well laminin-coated plates (Sigma) at 37degreesC under 5% CO2 in neurobasal medium (Gibco) supplemented with 2% B27 (Gibco), 1% pen/strep (Sigma), 1% glutamine (Sigma) and 0.2% nystatin (Sigma), in the presence or absence of 10 ng/ml VEGF165 (R&D Systems, obtained from the NIH-NCI Preclinical Repository). Twenty-four, 48 or 72 hrs post-plating, 10 microl of trypan blue dye was added for 5 min and the numbers of stained (dead) and unstained (live) cells were counted.
###end p 88
###begin title 89
Statistical analysis
###end title 89
###begin p 90
Values are expressed as mean+/-SD (unless specified); statistical analysis was performed using an unpaired Student t test (***: P<0.001, **: P<0.01, *: P<0.05, ns: P>0.05).
###end p 90
###begin title 91
Online supplemental material
###end title 91
###begin p 92
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s001">Fig. S1</xref>
###xml 125 132 122 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s002">Fig. S2</xref>
###xml 229 236 226 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s003">Fig. S3</xref>
###xml 326 333 323 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s004">Fig. S4</xref>
###xml 420 427 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003554.s005">Fig. S5</xref>
Fig. S1 shows VEGF-expressing astrocytes, characterized by GFAP and beta-gal staining, in adult VEGF-LacZ retina flat-mount. Fig. S2 demonstrates normal pericyte coverage of retinal microvessels 14 days after Ad-sFlt1 infection. Fig. S3 demonstrates the absence of GFAP up-regulation in Muller cells after Ad-sFlt1 infection. Fig. S4 shows the successive steps of photoreceptor sheets isolation by vibratome sectioning. Fig. S5 demonstrates the purity of the photoreceptor explants which stain positive for recoverin and lack the Muller cell specific markers, GFAP and glutamine synthetase (GS).
###end p 92
###begin title 93
Supporting Information
###end title 93
###begin p 94
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Expression of VEGF by astrocytes in adult retina. VEGF expressing cells were detected on retina flat-mounts of adult VEGF-lacZ mice by beta-gal staining. Co-staining with GFAP revealed a high number of astrocytes, with processes wrapping the retina vessels, expressing VEGF as shown by the blue staining of their cell bodies (black arrowheads). Some lacZ-positive GFAP-negative cells, presumably pericytes, are observed apposed to the vessel wall (white arrows). Scale bar are 100 microm.
###end p 94
###begin p 95
(5.90 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 64 68 <span type="species:ncbi:10090">Mice</span>
Normal pericyte coverage in microvessels of sFlt1 treated mice. Mice expressing Ad-null or Ad-sFlt1 for 14 days were perfused with h.m.w fluorescein dextran (green), the retinas were dissected, flat mounted and stained for the pericyte marker, NG2 (red). No changes in the association of pericytes with the retinal microvessels were observed (arrows). Scale bar is 50 microm.
###end p 97
###begin p 98
(0.93 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
Absence of glial activation in the retina of sFlt1-expressing mice. Sections of eyes from mice infected by Ad-null and Ad-sFlt1 for 14 days were stained for the intermediate filament protein, glial fibrillary acidic protein (GFAP). Upregulation of GFAP in the Muller cells endfeet and processes is associated with an ongoing injury response. However, GFAP appeared normally restricted to the astrocytes in the GCL of both Ad-null and Ad-sFlt1 mice. GCL: ganglion cell layer; IPL: inner plexiform layer; INL: inner nuclear layer. Scale is bar 100 microm.
###end p 100
###begin p 101
(1.06 MB TIF)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Isolation of photoreceptors sheets. Adult mouse retinas were flat-mounted onto a 20% gelatin block and sectioned along the horizontal plane until the ONL was reached. (A) Photograph of a gelatin block stained by hematoxylin and eosin (H&E) showing that only the photoreceptors (ONL, IS and OS) remain after the inner layers are sectionned. (B) H&E staining of an isolated photoreceptor sheet that will be subsequently used for ONL explant or photoreceptor cell culture. OS: outer segment; IS, inner segment; ONL, outer nuclear layer. Scale bar is 100 microm in A and 50 microm in B.
###end p 103
###begin p 104
(0.93 MB TIF)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
Verification of the photoreceptor explant purity. ONL explants were co-stained for the photoreceptor marker, recoverin, and the Muller cell markers, GFAP and GS. All cells in the ONL explants were positive for recoverin, confirming the presence of photoreceptors. No GFAP- or GS-positive cells were detected. Some remnants of Muller cell basal processes could be observed (arrows), demonstrating the purity of the photoreceptor sheets. Positive control for GFAP and GS staining consisting of full retina sections were included (data not shown). Scale bar is 20 microm.
###end p 106
###begin p 107
(5.04 MB TIF)
###end p 107
###begin p 108
Click here for additional data file.
###end p 108
###begin p 109
The authors are grateful to Patricia Pearson for her expert assistance with the TEM, to Dr. Toshio Hisatomi for his help in TEM interpretation, to Ms. Christine Bagley for her editorial assistance and to Dr. Ananth Karumanchu for his continued interest and intellectual input.
###end p 109
###begin title 110
References
###end title 110
###begin article-title 111
Development and pathology of the hyaloid, choroidal and retinal vasculature.
###end article-title 111
###begin article-title 112
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival.
###end article-title 112
###begin article-title 113
VEGF expression and receptor activation in the choroid during development and in the adult.
###end article-title 113
###begin article-title 114
Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function.
###end article-title 114
###begin article-title 115
Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia.
###end article-title 115
###begin article-title 116
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity.
###end article-title 116
###begin article-title 117
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.
###end article-title 117
###begin article-title 118
Targeting VEGF-A to treat cancer and age-related macular degeneration.
###end article-title 118
###begin article-title 119
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
###end article-title 119
###begin article-title 120
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.
###end article-title 120
###begin article-title 121
###xml 59 63 <span type="species:ncbi:10116">rats</span>
Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.
###end article-title 121
###begin article-title 122
Pegaptanib for neovascular age-related macular degeneration.
###end article-title 122
###begin article-title 123
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
###end article-title 123
###begin article-title 124
Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. [erratum appears in Invest Ophthalmol Vis Sci 2000 Feb;41(2):368].
###end article-title 124
###begin article-title 125
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development.
###end article-title 125
###begin article-title 126
###xml 100 105 <span type="species:ncbi:9606">human</span>
Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina.
###end article-title 126
###begin article-title 127
Vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGFbeta), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy: association with inflammation and viral infection.
###end article-title 127
###begin article-title 128
Vascular Endothelial Cell Growth Factor-A. Not Just for Endothelial Cells Anymore.
###end article-title 128
###begin article-title 129
Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor.
###end article-title 129
###begin article-title 130
VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.
###end article-title 130
###begin article-title 131
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.
###end article-title 131
###begin article-title 132
###xml 130 134 <span type="species:ncbi:10090">mice</span>
Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
###end article-title 132
###begin article-title 133
Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration.
###end article-title 133
###begin article-title 134
Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
###end article-title 134
###begin article-title 135
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
###end article-title 135
###begin article-title 136
Bilateral choroidal ischaemia and serous retinal detachment in pre-eclampsia.
###end article-title 136
###begin article-title 137
Retinal pigment epithelial lesions associated with choroidal ischemia in preeclampsia.
###end article-title 137
###begin article-title 138
Multiple developmental roles of VEGF suggested by a LacZ-tagged allele.
###end article-title 138
###begin article-title 139
NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
###end article-title 139
###begin article-title 140
Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence.
###end article-title 140
###begin article-title 141
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.
###end article-title 141
###begin article-title 142
Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina.
###end article-title 142
###begin article-title 143
Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR.
###end article-title 143
###begin article-title 144
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
###end article-title 144
###begin article-title 145
Soluble endoglin contributes to the pathogenesis of preeclampsia.
###end article-title 145
###begin article-title 146
Vascular permeability in ocular disease and the role of tight junctions.
###end article-title 146
###begin article-title 147
Up-regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression.
###end article-title 147
###begin article-title 148
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
The major cell populations of the mouse retina.
###end article-title 148
###begin article-title 149
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Interpretation of the mouse electroretinogram.
###end article-title 149
###begin article-title 150
###xml 58 63 <span type="species:ncbi:9606">human</span>
In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1).
###end article-title 150
###begin article-title 151
BCL-2 family members and the mitochondria in apoptosis.
###end article-title 151
###begin article-title 152
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
###end article-title 152
###begin article-title 153
VEGF-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.
###end article-title 153
###begin article-title 154
###xml 56 61 <span type="species:ncbi:9606">human</span>
Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.
###end article-title 154
###begin article-title 155
Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
###end article-title 155
###begin article-title 156
Autocrine VEGF loops, signaling pathways, and acute leukemia regulation.
###end article-title 156
###begin article-title 157
Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin.
###end article-title 157
###begin article-title 158
Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
###end article-title 158
###begin article-title 159
Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation.
###end article-title 159
###begin article-title 160
Vascular endothelial growth factor localization in the adult.
###end article-title 160
###begin article-title 161
Autocrine VEGF signaling is required for vascular homeostasis.
###end article-title 161
###begin article-title 162
p53 in neuronal apoptosis.
###end article-title 162
###begin article-title 163
The Muller cell: a functional element of the retina.
###end article-title 163
###begin article-title 164
###xml 129 132 <span type="species:ncbi:10116">rat</span>
BDNF is upregulated by postnatal development and visual experience: quantitative and immunohistochemical analyses of BDNF in the rat retina.
###end article-title 164
###begin article-title 165
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina.
###end article-title 165
###begin article-title 166
Expression of neurotrophins and their receptors within the glial cells of retina and optic nerve.
###end article-title 166
###begin article-title 167
Effects of muller glia on cell survival and neuritogenesis in adult porcine retina in vitro.
###end article-title 167
###begin article-title 168
Role of Muller glia in neuroprotection and regeneration in the retina.
###end article-title 168
###begin article-title 169
Molecular determinants of retinal ganglion cell development, survival, and regeneration.
###end article-title 169
###begin article-title 170
Electrophysiological consequences of retinal hypoxia.
###end article-title 170
###begin article-title 171
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.
###end article-title 171
###begin article-title 172
Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes.
###end article-title 172
###begin article-title 173
Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor.
###end article-title 173
###begin article-title 174
Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor.
###end article-title 174
###begin article-title 175
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
Differential expression of VEGF isoforms in mouse during development and in the adult.
###end article-title 175
###begin article-title 176
Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.
###end article-title 176
###begin article-title 177
Vascular endothelial growth factor increases fenestral permeability in hepatic sinusoidal endothelial cells.
###end article-title 177
###begin article-title 178
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab.
###end article-title 178
###begin article-title 179
Cell turnover of capillaries.
###end article-title 179
###begin article-title 180
An activated form of transforming growth factor ss is produced by cocultures of endothelial cells and pericytes.
###end article-title 180
###begin article-title 181
PDGF, TGF-ss and heterotypic cell-cell interactions mediate the recruitment and differentiation of 10T1/2 cells to a smooth muscle cell fate.
###end article-title 181
###begin article-title 182
The mural cell in perspective.
###end article-title 182
###begin article-title 183
Retinal vascular patterns. IV. Diabetic retinopathy.
###end article-title 183
###begin article-title 184
Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization.
###end article-title 184
###begin article-title 185
TFGss is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells.
###end article-title 185
###begin article-title 186
###xml 90 94 <span type="species:ncbi:10090">mice</span>
Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells.
###end article-title 186
###begin article-title 187
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
###end article-title 187
###begin article-title 188
###xml 156 160 <span type="species:ncbi:10090">mice</span>
Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
###end article-title 188
###begin article-title 189
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors.
###end article-title 189
###begin article-title 190
Expression of acute-phase response proteins in retinal Muller cells in diabetes.
###end article-title 190
###begin article-title 191
###xml 21 24 <span type="species:ncbi:10116">rat</span>
Survival of purified rat photoreceptors in vitro is stimulated directly by fibroblast growth factor-2.
###end article-title 191
###begin article-title 192
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse.
###end article-title 192
###begin p 193
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 193
###begin p 194
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The research was supported by NIH grant EY05318 and EY015435 to P.D and by the Core grant for Vision Research P30EY14104. ND-EPSCOR (NSF) and R15 NSF057807 to D.C.D, by the Lincy Foundation and Discovery Eye Foundation to M.Y. B.D. is supported by NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 194

